We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Now's the Time to Buy These 5 Relative Price Strength Stocks
Read MoreHide Full Article
The novel coronavirus outbreak triggered an unprecedented sell-off in equities and bonds. Stocks were clobbered and major indices crashed regularly, while in a bizarre turn of events, the U.S. oil futures hit negative territory.
However, over the past few months, markets, securities and crude have rebounded off their pandemic lows. Restrictions have been loosened and the economy has reopened, with activity limping back toward normalcy. Meanwhile, certain drug candidates and treatments offer a ray of hope in the coronavirus fight.
While the heaviest losses may be in the rear-view mirror, with the S&P 500 and the tech-heavy Nasdaq attaining their all-time highs in September, the road to recovery remains long and uncertain amid concerns of soaring new coronavirus infections in many countries, the Fed’s cautious view of the American economy, the upcoming election-related uncertainty and simmering U.S.-China tensions. Confusion over the second stimulus package to prop up the economy is also weighing on the markets.
A few stocks held up even as the coronavirus-induced mayhem knocked down businesses and industries. With the market expected to remain volatile over the near to medium term, one of the ways such potential plays could be identified is to look for signs of relative price strength.
The Relative Price Strength Strategy
Earnings growth and valuation multiples are indeed important for investors to determine a stock's ability to offer considerable returns. But these are also essential in determining whether a stock’s price performance is better than its peers or the industry average.
If a stock’s performance is lacking that of the broader groups despite impressive earnings growth or valuation multiples, then something must be wrong.
It’s always advisable to stay away from these stocks and bet on those that are outperforming their respective industries or benchmarks. This is because betting on a winner always proves to be lucrative.
Then again, it is imperative that you determine whether or not an investment has relevant upside potential when considering stocks with significant relative price strength. Stocks delivering better than the S&P 500 over a period of 1 to 3 months at the least and having solid fundamentals indicate room for growth and are the best ways to go about this strategy.
Finally, it is important to find out whether analysts are optimistic about the upcoming earnings results of these companies. In order to do this, we have added positive estimate revisions for the current quarter’s (Q1) earnings to our screen. When a stock undergoes an upward revision, it leads to additional price gains.
Screening Parameters
Relative % Price change – 12 weeks greater than 0
Relative % Price change – 4 weeks greater than 0
Relative % Price change – 1 week greater than 0
(We have considered those stocks that have been outperforming the S&P 500 over the last 12 weeks, four weeks and one week.)
% Change (Q1) Est. over 4 Weeks greater than 0: Positive current-quarter estimate revisions over the last four weeks.
Zacks Rank equal to 1: Only Zacks Rank #1 (Strong Buy) stocks — that have returned more than 26% annually over the last 26 years and surpassed the S&P 500 in 23 of the last 26 years — can get through. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Current Price greater than or equal to $5 and Average 20-day Volume greater than or equal to 50,000: A minimum price of $5 is a good standard to screen low-priced stocks, while a high trading volume would imply adequate liquidity.
VGM Score less than or equal to B: Our research shows that stocks with a VGM Score of A or B when combined with a Zacks Rank #1 or 2 (Buy) offer the best upside potential.
Here are five of the 10 stocks that made it through the screen:
Crown Holdings, Inc. (CCK - Free Report) : Crown Holdings is a leading global manufacturer of packaging products for consumer goods. The 2020 Zacks Consensus Estimate for this Yardley, PA-based company indicates 11.7% earnings per share growth over 2019. Crown Holdings has a VGM Score of B.
Landstar System, Inc. (LSTR - Free Report) : An asset-light provider of integrated transportation management solutions, Landstar System has a VGM Score of A. Over 30 days, the Jacksonville, FL-based company has seen the Zacks Consensus Estimate for 2020 surge 16.5%.
Evercore Inc. (EVR - Free Report) : The New York, NY based company is a premier global independent investment banking advisory firm. The firm has a VGM Score of A and an excellent earnings surprise history, having surpassed estimates in each of the last four quarters by 66.26%, on average.
Altra Industrial Motion Corp. : Altra Industrial is one of the leading manufacturers and distributors of a diversified range of motion control, electromechanical power transmission and automation products. Sporting a VGM Score of B, this Braintree, MA-headquartered company’s expected EPS growth rate for three to five years currently stands at 15%, comparing favorably with the industry's growth rate of 10.8%.
Sleep Number Corporation (SNBR - Free Report) : Founded in 1987 and headquartered in Minneapolis, MN, Sleep Number is a seller of mattresses and other bedding products. The company has a VGM Score of A and an enviable earnings surprise history, having surpassed estimates in each of the last four quarters, delivering a positive earnings surprise of 55.89%, on average.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Image: Bigstock
Now's the Time to Buy These 5 Relative Price Strength Stocks
The novel coronavirus outbreak triggered an unprecedented sell-off in equities and bonds. Stocks were clobbered and major indices crashed regularly, while in a bizarre turn of events, the U.S. oil futures hit negative territory.
However, over the past few months, markets, securities and crude have rebounded off their pandemic lows. Restrictions have been loosened and the economy has reopened, with activity limping back toward normalcy. Meanwhile, certain drug candidates and treatments offer a ray of hope in the coronavirus fight.
While the heaviest losses may be in the rear-view mirror, with the S&P 500 and the tech-heavy Nasdaq attaining their all-time highs in September, the road to recovery remains long and uncertain amid concerns of soaring new coronavirus infections in many countries, the Fed’s cautious view of the American economy, the upcoming election-related uncertainty and simmering U.S.-China tensions. Confusion over the second stimulus package to prop up the economy is also weighing on the markets.
A few stocks held up even as the coronavirus-induced mayhem knocked down businesses and industries. With the market expected to remain volatile over the near to medium term, one of the ways such potential plays could be identified is to look for signs of relative price strength.
The Relative Price Strength Strategy
Earnings growth and valuation multiples are indeed important for investors to determine a stock's ability to offer considerable returns. But these are also essential in determining whether a stock’s price performance is better than its peers or the industry average.
If a stock’s performance is lacking that of the broader groups despite impressive earnings growth or valuation multiples, then something must be wrong.
It’s always advisable to stay away from these stocks and bet on those that are outperforming their respective industries or benchmarks. This is because betting on a winner always proves to be lucrative.
Then again, it is imperative that you determine whether or not an investment has relevant upside potential when considering stocks with significant relative price strength. Stocks delivering better than the S&P 500 over a period of 1 to 3 months at the least and having solid fundamentals indicate room for growth and are the best ways to go about this strategy.
Finally, it is important to find out whether analysts are optimistic about the upcoming earnings results of these companies. In order to do this, we have added positive estimate revisions for the current quarter’s (Q1) earnings to our screen. When a stock undergoes an upward revision, it leads to additional price gains.
Screening Parameters
Relative % Price change – 12 weeks greater than 0
Relative % Price change – 4 weeks greater than 0
Relative % Price change – 1 week greater than 0
(We have considered those stocks that have been outperforming the S&P 500 over the last 12 weeks, four weeks and one week.)
% Change (Q1) Est. over 4 Weeks greater than 0: Positive current-quarter estimate revisions over the last four weeks.
Zacks Rank equal to 1: Only Zacks Rank #1 (Strong Buy) stocks — that have returned more than 26% annually over the last 26 years and surpassed the S&P 500 in 23 of the last 26 years — can get through. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Current Price greater than or equal to $5 and Average 20-day Volume greater than or equal to 50,000: A minimum price of $5 is a good standard to screen low-priced stocks, while a high trading volume would imply adequate liquidity.
VGM Score less than or equal to B: Our research shows that stocks with a VGM Score of A or B when combined with a Zacks Rank #1 or 2 (Buy) offer the best upside potential.
Here are five of the 10 stocks that made it through the screen:
Crown Holdings, Inc. (CCK - Free Report) : Crown Holdings is a leading global manufacturer of packaging products for consumer goods. The 2020 Zacks Consensus Estimate for this Yardley, PA-based company indicates 11.7% earnings per share growth over 2019. Crown Holdings has a VGM Score of B.
Landstar System, Inc. (LSTR - Free Report) : An asset-light provider of integrated transportation management solutions, Landstar System has a VGM Score of A. Over 30 days, the Jacksonville, FL-based company has seen the Zacks Consensus Estimate for 2020 surge 16.5%.
Evercore Inc. (EVR - Free Report) : The New York, NY based company is a premier global independent investment banking advisory firm. The firm has a VGM Score of A and an excellent earnings surprise history, having surpassed estimates in each of the last four quarters by 66.26%, on average.
Altra Industrial Motion Corp. : Altra Industrial is one of the leading manufacturers and distributors of a diversified range of motion control, electromechanical power transmission and automation products. Sporting a VGM Score of B, this Braintree, MA-headquartered company’s expected EPS growth rate for three to five years currently stands at 15%, comparing favorably with the industry's growth rate of 10.8%.
Sleep Number Corporation (SNBR - Free Report) : Founded in 1987 and headquartered in Minneapolis, MN, Sleep Number is a seller of mattresses and other bedding products. The company has a VGM Score of A and an enviable earnings surprise history, having surpassed estimates in each of the last four quarters, delivering a positive earnings surprise of 55.89%, on average.
You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and test them first before taking the investment plunge.
The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.
Click here to sign up for a free trial to the Research Wizard today
Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.
Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.